Trial Master File (TMF) Management

Role of TMF in Sponsor and CRO Inspection Outcomes

Posted on digi By digi

The Trial Master File (TMF) serves as the cornerstone of Good Clinical Practice (GCP) compliance. It contains the essential documents that enable evaluation of the conduct of a clinical trial and the quality of the data produced. Both sponsors and Contract Research Organizations (CROs) have critical responsibilities regarding the TMF’s completeness, accuracy, and availability during inspections by authorities like the FDA, EMA, or MHRA.
Click to read the full article.

Inspection Readiness, Trial Master File (TMF) Management

Common TMF Findings During FDA/EMA Audits

Posted on digi By digi

The Trial Master File (TMF) is a central component of every clinical trial inspection conducted by global health authorities. Regulatory bodies like the U.S. FDA and EMA rely on the TMF to assess the quality, integrity, and conduct of the trial. A well-maintained TMF reflects sponsor oversight, GCP compliance, and operational accountability across all phases of the study.

Click to read the full article.

Inspection Readiness, Trial Master File (TMF) Management

Responding to TMF-Related 483 Observations

Posted on digi By digi

A Form FDA 483 is issued when an FDA inspector observes conditions that may violate Good Clinical Practice (GCP) during an inspection. For clinical trials, the Trial Master File (TMF) is often a focal point of these observations. Whether due to missing documents, poor audit trails, delayed filings, or lack of oversight, TMF-related 483s carry serious implications for trial validity and regulatory approval timelines.

Click to read the full article.

Inspection Readiness, Trial Master File (TMF) Management

Training Teams for Real-Time TMF Access During Audits

Posted on digi By digi

As regulatory inspections become increasingly digital and time-sensitive, the ability of clinical research teams to retrieve Trial Master File (TMF) documents in real time is a critical success factor. Authorities such as the FDA and EMA expect documents to be readily accessible during audits, and delays can lead to observations or critical findings.

Click to read the full article.

Inspection Readiness, Trial Master File (TMF) Management

Site TMF vs Sponsor TMF: Harmonization Tips

Posted on digi By digi

The Trial Master File (TMF) is a collection of essential documents that enable the evaluation of the conduct of a clinical trial. While the Sponsor TMF includes oversight and operational documents, each clinical site maintains a Site TMF—often referred to as the Investigator Site File (ISF). Regulatory bodies such as the EMA and FDA emphasize the need for consistency and completeness across both.

Click to read the full article.

Inspection Readiness, Trial Master File (TMF) Management

Differences Between Archiving and Storage in TMF Management

Posted on digi By digi

In the world of clinical trials, “archiving” and “storage” are often used interchangeably. However, they are not the same. Misunderstanding their roles in Trial Master File (TMF) management can lead to non-compliance with GCP standards, regulatory observations, or even data loss. Understanding these differences is essential for regulatory teams, CRAs, and trial sponsors to align their document lifecycle strategies.

Click to read the full article.

Archiving Requirements, Trial Master File (TMF) Management

How Long to Retain TMF Documents Post-Trial

Posted on digi By digi

Clinical trial documents don’t lose relevance when a study ends. Regulatory bodies require sponsors, CROs, and sites to retain essential records for years—sometimes decades—after trial completion. This long-term retention ensures that all trial activities remain traceable, auditable, and compliant with Good Clinical Practice (GCP) standards.

Click to read the full article.

Archiving Requirements, Trial Master File (TMF) Management